News

Our News

Stablepharma's mission to eliminate the cold chain - an interview by Health Tech World

Published on: 12/10/2021

Stablepharma completes the first close of Series A raise with £2 million following a number of high-profile partnership announcements

Published on: 17/09/2021

Alan Boyd, of Boyd Consultants & Advisor to Stablepharma, talks about his work, collaborations and the impact of the Pandemic

Published on: 10/08/2021

Özgür Tuncer CEO talks about Developing Thermostable Vaccines To Improve Accessibility Worldwide

Published on: 30/07/2021

Stablepharma partners with the University of Strathclyde to advance their COVID mRNA vaccine thermo-stabilisation technology

Published on: 21/07/2021

Stablepharma appoints Professor Saul Faust to the Advisory Board

Published on: 01/06/2021

Stablepharma Response

Published on: 24/05/2021

Stablepharma awarded £50,000 as part of UK research and innovation program

Published on: 11/04/2021

Stablepharma and BB-NCIPD collaborating on Td vaccine

Published on: 06/04/2021

Can chemistry thaw the vaccine cold chain?

Published on: 21/01/2021

Stablepharma highlighted in European Pharmaceutical Review

Published on: 14/12/2020

Innovate UK Smart Grant awarded to vaccine stabilising company

Published on: 24/11/2020

StablevaX™ United States of America patent granted!

Published on: 24/11/2020

Dr. Bruce Roser featured in a recent Pharma Technology article on Pandemic Logistics

Published on: 27/07/2020

Dr. Bruce Roser appears on the Irish Tech News podcast

Published on: 15/06/2020

New invention removes cold chain requirements for vaccines

Published on: 15/05/2020

Ability to stabilise and stockpile covid-19 vaccine is vital

Published on: 15/05/2020

Experienced R&D Manager Joins the Stablepharma Team

Published on: 27/02/2020

Science needs to find a new voice!

Published on: 22/01/2020

Stablepharma taking steps to bring a vision into reality

Published on: 26/11/2019

Stablepharma Board Announcements

Published on: 25/10/2019